Observational studyClinical pharmacokinetics2026

Utilization of Apixaban Pharmacokinetics for Dose Optimization in High-Risk Elderly Patients.

Rachel Goldstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.